Sensitivity to the non-COX inhibiting celecoxib derivative, OSU03012, is p21WAF1/CIP1dependent-Reference-Cited by-同舟云学术

Sensitivity to the non-COX inhibiting celecoxib derivative, OSU03012, is p21WAF1/CIP1dependent

Published:2008-12-15 Issue:12 Volume:123 Page:2931-2938
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ding Haiming,Han Chunhua,Guo Dongmei,Wang Dasheng,Duan Wenrui,Chen Ching-Shih,D'Ambrosio Steven M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference47 articles.

1. Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours;Kucab;Breast Cancer Res,2005

2. Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor;Tseng;Mol Pharmacol,2006

3. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival;Caron;Mol Cancer Ther,2005

4. Cytotoxicity of a non-cyclooxygenase-2 inhibitory derivative of celecoxib in non-small-cell lung cancer A549 cells;Tong;Lung Cancer,2006

5. A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growth;Li;J Gastrointest Surg,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of Anti-inflammatory Molecules in the Chemoprevention of Breast Cancer;Recent Advances in Inflammation & Allergy Drug Discovery;2022-09

2. Chidamide augment sorafenib-derived anti-tumor activities in human osteosarcoma cells lines and xenograft mouse model;Medical Oncology;2022-04-28

3. Anti-Inflammatory Drugs as Anticancer Agents;International Journal of Molecular Sciences;2020-04-09

4. ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21(CIP1/WAF1)in human cancer cells;British Journal of Pharmacology;2014-06-10

5. Exploiting Celecoxib in Cancer Therapy;Mitochondria: The Anti- cancer Target for the Third Millennium;2014